HomeNews

News

  • Scientists discover the role of genes in Alzheimer’s Disease

    • June 5, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Esketamine displays positive Ph 3 trial outcomes for Depression

    • June 3, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Rxulti (brexpiprazole) for Schizophrenia gets positive CHMP opinion by EMA

    • June 3, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Aimovig for Migraine receives positive CHMP opinion by EMA, might get approved soon in EU

    • June 2, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Recent study investigated RRMS to SPMS progression in MS patients

    • June 1, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Immunosuppressants might lower Parkinson’s risk

    • June 1, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Alzheimer’s drug by Cortexyme receives $76m fund for Ph 2 clinical research

    • May 31, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Rituximab shows efficacy in RRMS and Progressive MS patients, recent study underlines

    • May 31, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Parkinson’s drug ALK4290 by Alkahest receives Grant for Preclinical Evaluation

    • May 31, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • EMA Validates MAA Submission for Acorda’s INBRIJA for Parkinson’s

    • May 31, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more